Advanced Search

National Health (Pharmaceutical Benefits - Early Supply) Amendment Instrument 2014 (No. 5) - specification under subsection 84AAA(2) (No. PB 69 of 2014)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
 
PB 69 of 2014
National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 5) – specification under subsection 84AAA(2)
 
National Health Act 1953
 
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 15 August 2014
 
 
 
 
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
 
 
___________________________________________________________________________
 
 
Amendment determination – Pharmaceutical Benefits – Early Supply
 
 
1          Name of Instrument
 
(1)           This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 5) – specification under subsection 84AAA(2).
 
(2)           This Instrument may also be cited as PB 69 of 2014.
 
 
2          Commencement
 
This Instrument commences on 1 September 2014.
 
3          Amendment of PB 30 of 2009
 
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).
 
Schedule 1        Amendments
 
[1]        Schedule 1, entry for Oxprenolol
omit:
 
Tablet containing oxprenolol hydrochloride 20 mg
Oral
100
5